Royal Bank of Canada’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-479
| Closed | -$66K | – | 7209 |
|
|
2018
Q2 | $66K | Buy |
479
+342
| +250% | +$31.1K | ﹤0.01% | 5030 |
|
|
2018
Q1 | $11K | Sell |
137
-143
| -51% | -$10.6K | ﹤0.01% | 5699 |
|
|
2017
Q4 | $19K | Sell |
280
-1,239
| -82% | -$64.3K | ﹤0.01% | 5627 |
|
|
2017
Q3 | $62K | Sell |
1,519
-17,475
| -92% | -$674K | ﹤0.01% | 5298 |
|
|
2017
Q2 | $755K | Sell |
18,994
-463
| -2% | -$17K | ﹤0.01% | 3323 |
|
|
2017
Q1 | $628K | Sell |
19,457
-638
| -3% | -$15.9K | ﹤0.01% | 3459 |
|
|
2016
Q4 | $356K | Sell |
20,095
-4,887
| -20% | -$105K | ﹤0.01% | 4051 |
|
|
2016
Q3 | $583K | Sell |
24,982
-694
| -3% | -$15.8K | ﹤0.01% | 3588 |
|
|
2016
Q2 | $479K | Buy |
25,676
+100
| +0.4% | +$1.81K | ﹤0.01% | 3745 |
|
|
2016
Q1 | $465K | Sell |
25,576
-510
| -2% | -$8.22K | ﹤0.01% | 3710 |
|
|
2015
Q4 | $549K | Sell |
26,086
-883
| -3% | -$17K | ﹤0.01% | 3684 |
|
|
2015
Q3 | $498K | Buy |
26,969
+2,736
| +11% | +$68.3K | ﹤0.01% | 3512 |
|
|
2015
Q2 | $820K | Buy |
24,233
+10,343
| +74% | +$416K | ﹤0.01% | 3094 |
|
|
2015
Q1 | $668K | Buy |
13,890
+11,466
| +473% | +$520K | ﹤0.01% | 3240 |
|
|
2014
Q4 | $54K | Buy |
2,424
+1,824
| +304% | +$42.1K | ﹤0.01% | 5024 |
|
|
2014
Q3 | $11K | Sell |
600
-19,900
| -97% | -$475K | ﹤0.01% | 5466 |
|
|
2014
Q2 | $553K | Buy |
20,500
+10,900
| +114% | +$276K | ﹤0.01% | 3314 |
|
|
2014
Q1 | $310K | Sell |
9,600
-11,200
| -54% | -$364K | ﹤0.01% | 3738 |
|
|
2013
Q4 | $496K | Buy |
+20,800
| New | +$581K | ﹤0.01% | 3427 |
|
Royal Bank of Canada's FMI Position: Q3 2018 in Review
Royal Bank of Canada sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 479 shares — an estimated $66K sold.
Royal Bank of Canada first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $820K in Q2 2015. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Royal Bank of Canada reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Royal Bank of Canada sold 479 Foundation Medicine, Inc. shares in Q3 2018, an estimated $66K.
- Royal Bank of Canada first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Royal Bank of Canada's Foundation Medicine, Inc. position peaked at $820K in Q2 2015.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Royal Bank of Canada's 13F filing for Q3 2018, filed 14 Nov 2018.